Eastgate Biotech 

$0
2
+$0+0% Thursday 15:02

統計

當日最高
0.01
當日最低
0.01
52週最高
0.01
52週最低
0
成交量
750
平均成交量
7,035
市值
205,754
市盈率
-
股息收益率
-
股息
-

收益

4Mar預期
Q4 2016
Q1 2017
Q2 2017
Q4 2017
Q2 2018
Q3 2018
Q4 2018
-0
-0
-0
0
預期每股收益
0
實際每股收益
0

人們還關注

此列表基於在 Stock Events 上關注 ETBI 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Pharmaceuticals: Major
Health Technology
Finance and Insurance
Commodity Contracts Dealing
EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.
Show more...
首席執行官
員工
2
國家
US
ISIN
US2772531008

上市公司